Braidwell LP Xenon Pharmaceuticals Inc. Transaction History
Braidwell LP
- $3.53 Trillion
- Q3 2024
A detailed history of Braidwell LP transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Braidwell LP holds 2,707,255 shares of XENE stock, worth $108 Million. This represents 3.02% of its overall portfolio holdings.
Number of Shares
2,707,255
Previous 2,560,573
5.73%
Holding current value
$108 Million
Previous $99.8 Billion
6.76%
% of portfolio
3.02%
Previous 3.13%
Shares
8 transactions
Others Institutions Holding XENE
# of Institutions
212Shares Held
70.2MCall Options Held
88.3KPut Options Held
28.8K-
Avoro Capital Advisors LLC New York, NY5.67MShares$226 Million3.36% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.6MShares$183 Million1.77% of portfolio
-
Wellington Management Group LLP Boston, MA3.84MShares$153 Million0.03% of portfolio
-
Commodore Capital LP New York, NY2.7MShares$107 Million9.03% of portfolio
-
Capital World Investors Los Angeles, CA2.68MShares$107 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.48B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...